Document:

Form of Second Amended and Restated Employment Agreement

 Exhibit 10.31 
 [SECOND] AMENDED AND RESTATED EMPLOYMENT AGREEMENT 
 THIS [SECOND] AMENDED AND RESTATED EMPLOYMENT
AGREEMENT (this “Agreement”) is entered into by and between Cadence Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and
                     (“Executive”), and shall be effective as of
                    , 2008 (the “Effective Date”). 
 WHEREAS, Executive and Company are parties to that certain Employment Agreement dated as of                     ,
            , [as amended and restated on                     ,
            ,] (the “Original Agreement”). 
 WHEREAS, Executive
and Company desire to amend and restate the Original Agreement on the terms and conditions set forth herein. 
 NOW, THEREFORE, in
consideration of the mutual promises herein contained, the parties agree as follows: 
 1. Definitions. As used in this Agreement, the
following terms shall have the following meanings: 
 (a) Board. “Board” means the Board of Directors of the Company.

 (b) Bonus. “Bonus” means an amount equal to (i) the bonus awarded to Executive for the fiscal year prior to
the date of termination (which bonus shall be annualized to the extent Executive was not employed for the entire fiscal year prior to the date of termination), or (ii) if Executive has not received a bonus because Executive was not employed by
the Company for a sufficient period of time, Executive’s target annual bonus for the fiscal year in which the date of termination occurs. If any portion of the bonuses awarded to Executive consisted of securities or other property, the fair
market value thereof shall be determined in good faith by the Board. 
 (c) Cause. “Cause” means any of the
following: 
 (i) the commission of an act of fraud, embezzlement or dishonesty by Executive that has a material adverse impact on the
Company or any successor or affiliate thereof; 
 (ii) a conviction of, or plea of “guilty” or “no contest” to, a felony
by Executive; 
 (iii) any unauthorized use or disclosure by Executive of confidential information or trade secrets of the Company or any
successor or affiliate thereof that has a material adverse impact on any such entity; 
 (iv) Executive’s gross negligence,
insubordination or material violation of any duty of loyalty to the Company or any other material misconduct on the part of Executive; 
 (v) Executive’s ongoing and repeated failure or refusal to perform or neglect of Executive’s duties as required by this Agreement, which failure, refusal or neglect 

 
continues for fifteen (15) days following Executive’s receipt of written notice from the Board or the Company’s Chief Executive Officer (the
“CEO”) or the President stating with specificity the nature of such failure, refusal or neglect; or 
 (vi)
Executive’s breach of any material provision of this Agreement; provided, however, that prior to the determination that “Cause” under this Section 1(c) has occurred, the Company shall (w) provide to Executive in
writing, in reasonable detail, the reasons for the determination that such “Cause” exists, (x) other than with respect to clause (v) above which specifies the applicable period of time for Executive to remedy his or her breach,
afford Executive a reasonable opportunity to remedy any such breach, (y) provide the Executive an opportunity to be heard prior to the final decision to terminate the Executive’s employment hereunder for such “Cause” and
(z) make any decision that such “Cause” exists in good faith. 
 The foregoing definition shall not in any way preclude or
restrict the right of the Company or any successor or affiliate thereof to discharge or dismiss Executive for any other acts or omissions, but such other acts or omissions shall not be deemed, for purposes of this Agreement, to constitute grounds
for termination for Cause. 
 (d) Change of Control. “Change of Control” means (i) a merger or consolidation of
the Company with or into any other corporation or other entity or person or (ii) a sale, lease, exchange or other transfer in one transaction or a series of related transactions of all or substantially all of the Company’s outstanding
securities or all or substantially all of the Company’s assets; provided, however, that the following events shall not constitute a “Change of Control”: (A) a merger or consolidation of the Company in which the holders of
the voting securities of the Company immediately prior to the merger or consolidation hold at least a majority of the voting securities in the successor corporation immediately after the merger or consolidation; (B) a sale, lease, exchange or
other transaction in one transaction or a series of related transactions of all or substantially all of the Company’s assets to a wholly-owned subsidiary corporation; (C) a mere reincorporation of the Company; or (D) a transaction
undertaken for the sole purpose of creating a holding company that will be owned in substantially the same proportion by the persons who held the Company’s securities immediately before such transaction. 
 (e) Code. “Code” means the Internal Revenue Code of 1986, as amended from time to time, and the Treasury Regulations and other
interpretive guidance issued thereunder. 
 (f) Good Reason. “Good Reason” means the occurrence of any of the
following events or conditions without Executive’s written consent: 
 (i) a material diminution in Executive’s authority, duties
or responsibilities; 
 (ii) a material diminution in Executive’s base compensation, except in connection with a general reduction in
the base compensation of the Company’s or any successor’s or affiliate’s personnel with similar status and responsibilities; 

 (iii) a material change in the geographic location at which Executive must perform his duties; or

 (iv) any other action or inaction that constitutes a material breach by the Company or any successor or affiliate of its obligations to
Executive under this Agreement. 
 Executive must provide written notice to the Company of the occurrence of any of the foregoing events or
conditions without Executive’s written consent within ninety (90) days of the occurrence of such event. The Company or any successor or affiliate shall have a period of thirty (30) days to cure such event or condition after receipt of
written notice of such event from Executive. Any voluntary termination of Executive’s employment for “Good Reason” following such thirty (30) day cure period must occur no later than the date that is six (6) months following
the initial occurrence of one of the foregoing events or conditions without Executive’s written consent and such voluntary termination of Executive’s employment shall be treated as an involuntary termination of employment. 
 (g) Permanent Disability. Executive’s “Permanent Disability” shall be deemed to have occurred if Executive shall become
physically or mentally incapacitated or disabled or otherwise unable fully to discharge his or her duties hereunder for a period of ninety (90) consecutive calendar days or for one hundred twenty (120) calendar days in any one hundred
eighty (180) calendar-day period. The existence of Executive’s Permanent Disability shall be determined by the Company on the advice of a physician chosen by the Company and the Company reserves the right to have the Executive examined by
a physician chosen by the Company at the Company’s expense. 
 (h) Stock Awards. “Stock Awards” means all stock
options, restricted stock and such other awards granted pursuant to the Company’s stock option and equity incentive award plans or agreements and any shares of stock issued upon exercise thereof. 
 2. Services to Be Rendered. 
 (a)
Duties and Responsibilities. Executive shall serve as                      of the Company[, but shall not perform policy-making functions for
the Company or be designated an “officer” of the Company, as such term is defined under Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended]. In the performance of such duties, Executive shall report directly to the
[Board][CEO][Chief Medical Officer (“CMO”)] and shall be subject to the direction of the [Board][CEO][CMO] and to such limits upon Executive’s authority as the Board or the CEO or [CMO] may from time to time impose. [In the
event of the [CEO][CMO]’s incapacity or unavailability, Executive shall report directly to the CEO [or President], or such other officer of the Company as the CEO may designate, or be subject to the direction of the Board or its designee.]
Executive hereby consents to serve as an officer and/or director of the Company or any subsidiary or affiliate thereof without any additional salary or compensation, if so requested by the [Board][CEO]. Executive shall be employed by the Company on
a full time basis. Executive’s primary place of work shall be the Company’s facility in San Diego, California, or such other location within San Diego County as may be designated by the [Board][CEO] from time to time. Executive shall also
render services at such other places within or outside the United States as the [Board][CEO][or CMO] may direct from time to time. 

 
Executive shall be subject to and comply with the policies and procedures generally applicable to senior executives of the Company to the extent the same are
not inconsistent with any term of this Agreement. 
 (b) Exclusive Services. Executive shall at all times faithfully, industriously
and to the best of his or her ability, experience and talent perform to the satisfaction of the Board, the CEO and the President all of the duties that may be assigned to Executive hereunder and shall devote substantially all of his or her
productive time and efforts to the performance of such duties. Subject to the terms of the Employee Proprietary Information and Inventions Agreement referred to in Section 5(b), this shall not preclude Executive from devoting time to personal
and family investments or serving on community and civic boards, or participating in industry associations, provided such activities do not interfere with his or her duties to the Company, as determined in good faith by the [Board][ CEO]. Executive
agrees that he or she will not join any boards, other than community and civic boards (which do not interfere with his or her duties to the Company), without the prior approval of the [Board][ CEO]. 
 3. Compensation and Benefits. The Company shall pay or provide, as the case may be, to Executive the compensation and other benefits and rights
set forth in this Section 3. 
 (a) Base Salary. The Company shall pay to Executive a base salary of
                     per year, payable in accordance with the Company’s usual pay practices (and in any event no less frequently than monthly).
Executive’s base salary shall be subject to review annually by and at the sole discretion of the Compensation Committee of the Board or its designee. 
 (b) Bonus. Executive shall participate in any bonus plan that the Board or its designee may approve for the senior executives of the Company. 
 (c) Benefits. Executive shall be entitled to participate in benefits under the Company’s benefit plans and arrangements, including, without
limitation, any employee benefit plan or arrangement made available in the future by the Company to its senior executives, subject to and on a basis consistent with the terms, conditions and overall administration of such plans and arrangements. The
Company shall have the right to amend or delete any such benefit plan or arrangement made available by the Company to its senior executives and not otherwise specifically provided for herein. 
 (d) Expenses. The Company shall reimburse Executive for reasonable out-of-pocket business expenses incurred in connection with the performance of
his or her duties hereunder, subject to (i) such policies as the Company may from time to time establish, [and] (ii) Executive furnishing the Company with evidence in the form of receipts satisfactory to the Company substantiating the
claimed expenditures[, (iii) Executive receiving advance approval from the CEO in the case of expenses for travel outside of North America, and (iv) Executive receiving advance approval from the CEO in the case of expenses (or a series of
related expenses) in excess of $10,000]. Any amounts payable under this Section 3(d) shall be made in accordance with Treasury Regulation Section 1.409A-3(i)(1)(iv) and shall be paid in accordance with Company policy but in no event later
than the last day of Executive’s taxable year following the taxable year in which Executive incurred the expenses. The amounts provided under this 

 
Section 3(d) during any taxable year of Executive’s will not affect such amounts provided in any other taxable year of Executive’s, and
Executive’s right to reimbursement for such amounts shall not be subject to liquidation or exchange for any other benefit. The two preceding sentences shall only apply with respect to expense reimbursements that are taxable to Executive.

 (e) Paid Time Off. Executive shall be entitled to such periods of paid time off (“PTO”) each year as provided from
time to time under the Company’s PTO guidelines; provided that Executive shall be entitled to at least four (4) weeks of PTO per year. 
 (f) Equity Plans. Executive shall be entitled to participate in any equity or other employee benefit plan that is generally available to senior executive officers, as distinguished from general management, of the Company. Except as
otherwise provided in this Agreement, Executive’s participation in and benefits under any such plan shall be on the terms and subject to the conditions specified in the governing document of the particular plan. 
 (g) Stock Award Acceleration. 
 (i)
If Executive’s employment is terminated by the Company without Cause, by Executive for Good Reason, or as a result of Executive’s death or Permanent Disability, the vesting and/or exercisability of each of Executive’s outstanding
Stock Awards shall be automatically accelerated on the date of termination as to the number of Stock Awards that would vest over the twelve (12) month period following the date of termination had Executive remained continuously employed by the
Company during such period. 
 (ii) The vesting and exercisability of fifty percent (50%) of Executive’s outstanding Stock Awards
shall be automatically accelerated on the date of a Change of Control. 
 (iii) If Executive’s employment is terminated by the Company
without Cause or by Executive for Good Reason within three (3) months prior to or twelve (12) months following a Change of Control, the vesting and/or exercisability of any outstanding unvested portions of Executive’s Stock Awards
shall be automatically accelerated on the later of (A) the date of termination or (B) the date of the Change of Control. In addition, Executive’s Stock Awards may be exercised by Executive (or Executive’s guardian or legal
representative) until the latest of (A) three (3) months after the date of termination, (B) with respect to any portion of the Stock Awards that become exercisable on the date of a Change of Control pursuant to this
Section 3(g)(iii), three (3) months after the date of the Change of Control, or (C) such longer period as may be specified in the applicable Stock Award agreement; provided, however, that in no event shall any Stock Award
remain exercisable beyond the original outside expiration date of such Stock Award. 
 (iv) The vesting pursuant to clauses (i),
(ii) and (iii) of this Section 3(g) shall be cumulative. The foregoing provisions are hereby deemed to be a part of each Stock Award and to supersede any less favorable provision in any agreement or plan regarding such Stock Award.

 4. Termination and Severance. Executive shall be entitled to receive benefits upon termination of
employment only as set forth in this Section 4: 
 (a) At-Will Employment; Termination. The Company and Executive acknowledge
that Executive’s employment is and shall continue to be at-will, as defined under applicable law, and that Executive’s employment with the Company may be terminated by either party at any time for any or no reason, with or without notice.
If Executive’s employment terminates for any reason, Executive shall not be entitled to any payments, benefits, damages, awards or compensation other than as provided in this Agreement. Executive’s employment under this Agreement shall be
terminated immediately on the death of Executive. 
 (b) Termination by Death. If Executive’s employment is terminated by death,
Executive’s estate shall be entitled to receive (i) Executive’s fully earned but unpaid base salary for days worked prior to the date of Executive’s death at the rate then in effect, plus all other amounts to which Executive is
entitled under any compensation plan or practice of the Company at the time of Executive’s death, (ii) a lump sum cash payment equal to Executive’s annual base salary as in effect immediately prior to the date of death, payable within
thirty (30) days following the date of Executive’s death, (iii) a lump sum cash payment equal to Executive’s Bonus for the year in which Executive’s death occurs prorated for the period during such year Executive was
employed prior to his or her death, payable within thirty (30) days following the date of Executive’s death, and (iv) for the period beginning on the date of death and ending on the date which is twelve (12) full months following
the date of death (or, if earlier, the date on which the applicable continuation period under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”) expires), the Company shall reimburse Executive’s
eligible dependents for the costs associated with continuation coverage for such eligible dependents pursuant to COBRA (provided that Executive’s dependents shall be solely responsible for all matters relating to such continuation of coverage
pursuant to COBRA, including, without limitation, election of such coverage and his or her timely payment of premiums). 
 (c)
Termination for Permanent Disability. If Executive’s employment is terminated by the Company as a result of Executive’s Permanent Disability, Executive shall be entitled to receive (i) Executive’s fully earned but unpaid
base salary for days worked prior to the commencement of Executive’s disability leave at the rate then in effect, plus all other amounts to which Executive is entitled under any compensation plan or practice of the Company at the time such
payments are due, (ii) subject to Executive’s continued compliance with Section 5, a lump sum cash payment equal to Executive’s annual base salary as in effect immediately prior to the date of termination, payable within ten
(10) days following the effective date of Executive’s Release (as defined below), (iii) subject to Executive’s continued compliance with Section 5, a lump sum cash payment equal to Executive’s Bonus for the year in
which the date of termination occurs prorated for the period during such year Executive was employed prior to the date of termination, within ten (10) days following the effective date of Executive’s Release (as defined below),
(iv) subject to Executive’s continued compliance with Section 5, for the period beginning on the date of termination and ending on the date which is twelve (12) full months following the date of termination (or, if earlier, the
date on which the applicable continuation period under COBRA expires), the Company shall (A) reimburse Executive for the costs associated with continuation coverage pursuant to COBRA for Executive and his or her eligible dependents who were
covered under the Company’s health plans as of the date of Executive’s termination 

 
(provided that Executive shall be solely responsible for all matters relating to his or her continuation of coverage pursuant to COBRA, including, without
limitation, his or her election of such coverage and his or her timely payment of premiums), and (v) the Company shall pay for and provide Executive and such eligible dependents with a lump sum payment sufficient to pay the premiums for life
insurance benefits coverage for the twelve (12) month period commencing on the date of termination to the extent such Executive and/or such dependents were receiving such benefits prior to the date of Executive’s termination, which payment
shall be paid within ten (10) days following the effective date of Executive’s Release. 
 (d) Termination Without Cause or For
Good Reason. 
 (i) Termination Without Cause or For Good Reason. If Executive’s employment is terminated by the Company
without Cause or by Executive for Good Reason more than three (3) months prior to a Change of Control or more than twelve (12) months following a Change of Control, Executive shall be entitled to receive, in lieu of any severance benefits
to which Executive may otherwise be entitled under any severance plan or program of the Company (other than as provided in Section 3(g) of this Agreement), the benefits provided below: 
 (A) the Company shall pay to Executive his or her fully earned but unpaid base salary, when due, through the date of termination at the
rate then in effect, plus all other amounts to which Executive is entitled under any compensation plan or practice of the Company at the time of termination; 
 (B) subject to Executive’s continued compliance with Section 5, Executive shall be entitled to receive a lump sum cash payment
equal to Executive’s annual base salary as in effect immediately prior to the date of termination, payable within ten (10) days following the effective date of Executive’s Release (as defined below); plus 
 (C) subject to Executive’s continued compliance with Section 5, for the period beginning on the date of termination and ending
on the date which is twelve (12) full months following the date of termination (or, if earlier, the date on which the applicable continuation period under COBRA expires), the Company shall reimburse Executive for the costs associated with
continuation coverage pursuant to COBRA for Executive and his or her eligible dependents who were covered under the Company’s health plans as of the date of Executive’s termination (provided that Executive shall be solely responsible for
all matters relating to his or her continuation of coverage pursuant to COBRA, including, without limitation, his or her election of such coverage and his or her timely payment of premiums); and 
 (D) subject to Executive’s continued compliance with Section 5, the Company shall pay for and provide Executive and such
eligible dependents with a lump sum payment sufficient to pay the premiums for life insurance benefits coverage for the twelve (12) month period commencing on the date of termination to the extent such Executive and/or such dependents were
receiving such benefits prior to the date of Executive’s termination, which payment shall be paid within ten (10) days following the effective date of Executive’s Release; and 

 (E) subject to Executive’s continued compliance with Section 5, for the period
beginning on the date of termination and ending on the date which is twelve (12) full months following the date of termination, Executive shall be entitled to executive-level outplacement services at the Company’s expense, not to exceed
$15,000. Such services shall be provided by a firm selected by Executive from a list compiled by the Company. 
 (F) To the
extent Executive is entitled to payments or benefits under Section 4(d)(ii), then Executive shall receive the payments and benefits described in Section 4(d)(ii) in lieu of the payments and benefits described in this Section 4(d)(i).

 (ii) Termination Without Cause or By Executive For Good Reason In Connection With a Change of Control. If Executive’s
employment is terminated by the Company without Cause or by Executive for Good Reason within three (3) months prior to or twelve (12) months following a Change of Control (provided that, in the event the date of Executive’s
termination of employment precedes the consummation of a Change of Control, such Change of Control must occur no later than March 1 of the calendar year following the year in which Executive’s termination of employment occurs), Executive
shall be entitled to receive, in lieu of any severance benefits to which Executive may otherwise be entitled under any severance plan or program of the Company (other than as provided in Section 3(g) of this Agreement), the benefits provided
below: 
 (A) the Company shall pay to Executive his or her fully earned but unpaid base salary, when due, through the date
of termination at the rate then in effect, plus all other amounts to which Executive is entitled under any compensation plan or practice of the Company at the time of termination; 
 (B) subject to Executive’s continued compliance with Section 5, Executive shall be entitled to receive a lump sum cash payment,
payable within ten (10) days following the effective date of Executive’s Release (or, in the event the date of termination precedes the consummation of a Change of Control, the payment of Executive’s prorated Bonus pursuant to clause
(2) below shall be paid within ten (10) days following the date of the Change in Control but in no event later than March 15 of the calendar year following the year in which Executive’s termination of employment occurs), equal to
the sum of: 
 (1) Executive’s annual base salary as in effect immediately prior to the date of termination, plus

 (2) an amount equal to Executive’s Bonus for the year in which the date of termination occurs prorated for the period
during such year Executive was employed prior to the date of termination; 
 (C) subject to Executive’s continued
compliance with Section 5, for the period beginning on the date of termination and ending on the date which is twelve (12) full months following the date of termination (or, if earlier, the date on which the applicable continuation period
under COBRA expires), the Company shall reimburse 

 
Executive for the costs associated with continuation coverage pursuant to COBRA for Executive and his or her eligible dependents who were covered under the
Company’s health plans as of the date of Executive’s termination (provided that Executive shall be solely responsible for all matters relating to his or her continuation of coverage pursuant to COBRA, including, without limitation, his or
her election of such coverage and his or her timely payment of premiums), and 
 (D) subject to Executive’s continued
compliance with Section 5, the Company shall pay for and provide Executive and such eligible dependents with a lump sum payment sufficient to pay the premiums for life insurance benefits coverage for the twelve (12) month period commencing
on the date of termination to the extent such Executive and/or such dependents were receiving such benefits prior to the date of Executive’s termination, which payment shall be paid within ten (10) days following the effective date of
Executive’s Release; and 
 (E) subject to Executive’s continued compliance with Section 5, for the period
beginning on the date of termination and ending on the date which is twelve (12) full months following the date of termination, Executive shall be entitled to executive-level outplacement services at the Company’s expense, not to exceed
$15,000. Such services shall be provided by a firm selected by Executive from a list compiled by the Company. 
 (e) Termination for
Cause, Voluntary Resignation Without Good Reason. If Executive’s employment is terminated by the Company for Cause or by Executive without Good Reason (other than as a result of Executive’s death or Permanent Disability), the Company
shall not have any other or further obligations to Executive under this Agreement (including any financial obligations) except that Executive shall be entitled to receive (i) Executive’s fully earned but unpaid base salary, through the
date of termination at the rate then in effect, and (ii) all other amounts or benefits to which Executive is entitled under any compensation, retirement or benefit plan or practice of the Company at the time of termination in accordance with
the terms of such plans or practices, including, without limitation, any continuation of benefits required by COBRA or applicable law. In addition, if Executive’s employment is terminated by the Company for Cause or by Executive without Good
Reason (other than as a result of Executive’s death or Permanent Disability), all vesting of Executive’s unvested Stock Awards previously granted to him or her by the Company shall cease and none of such unvested Stock Awards shall be
exercisable following the date of such termination. The foregoing shall be in addition to, and not in lieu of, any and all other rights and remedies which may be available to the Company under the circumstances, whether at law or in equity.

 (f) Delay of Payments. If at the time of Executive’s termination of employment with the Company Executive is a
“specified employee” as defined in Section 409A of the Code, as determined by the Company in accordance with Section 409A of the Code, and the deferral of the commencement of any payments or benefits otherwise payable
hereunder as a result of such termination of employment is necessary in order to prevent any accelerated or additional tax under Section 409A of the Code, then the Company will defer the commencement of the payment of any such payments or
benefits hereunder (without any reduction in such payments or benefits ultimately paid or provided to Executive) until the date that is at least six (6) months following Executive’s termination of employment with the Company (or the
earliest date as is permitted under Section 409A of the Code). 

 (g) Release. As a condition to
Executive’s receipt of any post-termination benefits described in this Agreement, Executive shall execute and not revoke a general release of all claims in favor of the Company (the “Release”) substantially in the form attached
hereto. It is understood that, as specified in the applicable Release, Executive has a certain number of calendar days to consider whether to execute such Release and, if provided under applicable law, Executive may revoke such Release within seven
(7) calendar days after execution. Notwithstanding any provision to the contrary in this Agreement, no post-termination benefits described in this Agreement shall be paid pursuant to this Agreement unless, on or prior to the 60th day following the date of termination, Executive’s Release has been executed and remains effective on such date and any applicable revocation period has
expired without the Release being revoked by Executive. 
 (h) Exclusive Remedy. Except as otherwise expressly required by law (e.g.,
COBRA) or as specifically provided herein, all of Executive’s rights to salary, severance, benefits, bonuses and other amounts hereunder (if any) accruing after the termination of Executive’s employment shall cease upon such termination.
In the event of a termination of Executive’s employment with the Company, Executive’s sole remedy shall be to receive the payments and benefits described in this Section 4. In addition, Executive acknowledges and agrees that he or she
is not entitled to any reimbursement by the Company for any taxes payable by Executive as a result of the payments and benefits received by Executive pursuant to this Section 4, including, without limitation, any excise tax imposed by
Section 4999 of the Code. 
 (i) No Mitigation. The amount of any payment or benefit provided for in this Section 4 shall
not be reduced by any compensation earned by Executive as the result of employment by another employer or self-employment or by retirement benefits and, as provided in Sections 4(b), (c) or (d), Executive’s (or his or her dependents’)
right to continued healthcare and life insurance benefits following his or her termination of employment will terminate on the date on which the applicable continuation period under COBRA expires. In addition, loans, advances or other amounts owed
by Executive to the Company may be offset by the Company against amounts payable to Executive under this Section 4. 
 (j) Return of
the Company’s Property. If Executive’s employment is terminated for any reason, the Company shall have the right, at its option, to require Executive to vacate his or her offices prior to or on the effective date of termination and to
cease all activities on the Company’s behalf. Upon the termination of his or her employment in any manner, as a condition to the Executive’s receipt of any post-termination benefits described in this Agreement, Executive shall immediately
surrender to the Company all lists, books and records of, or in connection with, the Company’s business, and all other property belonging to the Company, it being distinctly understood that all such lists, books and records, and other
documents, are the property of the Company. Executive shall deliver to the Company a signed statement certifying compliance with this Section 4(j) prior to the receipt of any post-termination benefits described in this Agreement. 

 (k) Waiver of the Company’s Liability. Executive recognizes that his or her employment is
subject to termination with or without Cause for any reason and therefore Executive agrees that Executive shall hold the Company harmless from and against any and all liabilities, losses, damages, costs and expenses, including but not limited to,
court costs and reasonable attorneys’ fees, which Executive may incur as a result of the termination of Executive’s employment. Executive further agrees that Executive shall bring no claim or cause of action against the Company for damages
or injunctive relief based on a wrongful termination of employment. Executive agrees that the sole liability of the Company to Executive upon termination of this Agreement shall be that determined by this Section 4. In the event this covenant
is more restrictive than permitted by laws of the jurisdiction in which the Company seeks enforcement thereof, this covenant shall be limited to the extent permitted by law. 
 5. Certain Covenants. 
 (a)
Noncompetition. Except as may otherwise be approved by the Board, during the term of Executive’s employment, Executive shall not have any ownership interest (of record or beneficial) in, or have any interest as an employee, salesman,
consultant, officer or director in, or otherwise aid or assist in any manner, any firm, corporation, partnership, proprietorship or other business that engages in any county, city or part thereof in the United States and/or any foreign country in a
business which competes directly or indirectly (as determined by the Board) with the Company’s business in such county, city or part thereof, so long as the Company, or any successor in interest of the Company to the business and goodwill of
the Company, remains engaged in such business in such county, city or part thereof or continues to solicit customers or potential customers therein; provided, however, that Executive may own, directly or indirectly, solely as an investment,
securities of any entity which are traded on any national securities exchange if Executive (x) is not a controlling person of, or a member of a group which controls, such entity; or (y) does not, directly or indirectly, own one percent
(1%) or more of any class of securities of any such entity. 
 (b) Confidential Information. Executive and the Company have
entered into the Company’s standard employee proprietary information and inventions agreement (the “Employee Proprietary Information and Inventions Agreement”). Executive agrees to perform each and every obligation of Executive
therein contained. 
 (c) Solicitation of Employees. Executive shall not during the term of Executive’s employment and for the
applicable severance period for which Executive receives severance benefits following any termination hereof pursuant to Section 4(c) or (d) above (regardless of whether Executive receives such severance benefits in a lump sum payment or
over the length of the severance period) (the “Restricted Period”), directly or indirectly, solicit or encourage to leave the employment of the Company or any of its affiliates, any employee of the Company or any of its affiliates.

 (d) Solicitation of Consultants. Executive shall not during the term of Executive’s employment and for the Restricted Period,
directly or indirectly, hire, solicit or encourage to cease work with the Company or any of its affiliates any consultant then under contract with the Company or any of its affiliates within one year of the termination of such consultant’s
engagement by the Company or any of its affiliates. 

 (e) Rights and Remedies Upon Breach. If Executive breaches or threatens to commit a breach of any
of the provisions of this Section 5 (the “Restrictive Covenants”), the Company shall have the following rights and remedies, each of which rights and remedies shall be independent of the other and severally enforceable, and all of
which rights and remedies shall be in addition to, and not in lieu of, any other rights and remedies available to the Company under law or in equity: 
 (i) Specific Performance. The right and remedy to have the Restrictive Covenants specifically enforced by any court having equity jurisdiction, all without the need to post a bond or any other security or to
prove any amount of actual damage or that money damages would not provide an adequate remedy, it being acknowledged and agreed that any such breach or threatened breach will cause irreparable injury to the Company and that money damages will not
provide adequate remedy to the Company; and 
 (ii) Accounting and Indemnification. The right and remedy to require Executive
(i) to account for and pay over to the Company all compensation, profits, monies, accruals, increments or other benefits derived or received by Executive or any associated party deriving such benefits as a result of any such breach of the
Restrictive Covenants; and (ii) to indemnify the Company against any other losses, damages (including special and consequential damages), costs and expenses, including actual attorneys’ fees and court costs, which may be incurred by them
and which result from or arise out of any such breach or threatened breach of the Restrictive Covenants. 
 (f) Severability of
Covenants/Blue Pencilling. If any court determines that any of the Restrictive Covenants, or any part thereof, is invalid or unenforceable, the remainder of the Restrictive Covenants shall not thereby be affected and shall be given full effect,
without regard to the invalid portions. If any court determines that any of the Restrictive Covenants, or any part thereof, are unenforceable because of the duration of such provision or the area covered thereby, such court shall have the power to
reduce the duration or area of such provision and, in its reduced form, such provision shall then be enforceable and shall be enforced. Executive hereby waives any and all right to attack the validity of the Restrictive Covenants on the grounds of
the breadth of their geographic scope or the length of their term. 
 (g) Enforceability in Jurisdictions. The Company and Executive
intend to and do hereby confer jurisdiction to enforce the Restrictive Covenants upon the courts of any jurisdiction within the geographical scope of such covenants. If the courts of any one or more of such jurisdictions hold the Restrictive
Covenants wholly unenforceable by reason of the breadth of such scope or otherwise, it is the intention of the Company and Executive that such determination not bar or in any way affect the right of the Company to the relief provided above in the
courts of any other jurisdiction within the geographical scope of such covenants, as to breaches of such covenants in such other respective jurisdictions, such covenants as they relate to each jurisdiction being, for this purpose, severable into
diverse and independent covenants. 
 (h) Definitions. For purposes of this Section 5, the term “Company” means not
only Cadence Pharmaceuticals, Inc., but also any company, partnership or entity which, directly or indirectly, controls, is controlled by or is under common control with Cadence Pharmaceuticals, Inc. 

 6. Insurance. The Company shall have the right to take out life, health, accident,
“key-man” or other insurance covering Executive, in the name of the Company and at the Company’s expense in any amount deemed appropriate by the Company. Executive shall assist the Company in obtaining such insurance, including,
without limitation, submitting to any required examinations and providing information and data required by insurance companies. 
 7.
Arbitration. Any dispute, claim or controversy based on, arising out of or relating to Executive’s employment or this Agreement shall be settled by final and binding arbitration in San Diego, California, before a single neutral
arbitrator in accordance with the National Rules for the Resolution of Employment Disputes (the “Rules”) of the American Arbitration Association, and judgment on the award rendered by the arbitrator may be entered in any court having
jurisdiction. Arbitration may be compelled pursuant to the California Arbitration Act (Code of Civil Procedure §§ 1280 et seq.). If the parties are unable to agree upon an arbitrator, one shall be appointed by the AAA in accordance with
its Rules. Each party shall pay the fees of its own attorneys, the expenses of its witnesses and all other expenses connected with presenting its case; however, Executive and the Company agree that, to the extent permitted by law, the arbitrator
may, in his or her discretion, award reasonable attorneys’ fees to the prevailing party; provided, however, that the prevailing party shall be reimbursed for such fees, costs and expenses within forty-five (45) days following any
such award, provided, further, that the parties’ obligations pursuant to this sentence shall terminate on the tenth (10th) anniversary of the date of Executive’s termination of employment. Other costs of the arbitration, including the
cost of any record or transcripts of the arbitration, AAA’s administrative fees, the fee of the arbitrator, and all other fees and costs, shall be borne by the Company. This Section 7 is intended to be the exclusive method for resolving
any and all claims by the parties against each other for payment of damages under this Agreement or relating to Executive’s employment; provided, however, that neither this Agreement nor the submission to arbitration shall limit the
parties’ right to seek provisional relief, including without limitation injunctive relief, in any court of competent jurisdiction pursuant to California Code of Civil Procedure § 1281.8 or any similar statute of an applicable jurisdiction.
Seeking any such relief shall not be deemed to be a waiver of such party’s right to compel arbitration. Both Executive and the Company expressly waive their right to a jury trial. 
 8. General Relationship. Executive shall be considered an employee of the Company within the meaning of all federal, state and local laws and
regulations including, but not limited to, laws and regulations governing unemployment insurance, workers’ compensation, industrial accident, labor and taxes. 
 9. Miscellaneous. 
 (a) Modification; Prior Claims. This Agreement and the Employee Proprietary
Information and Inventions Agreement set forth the entire understanding of the parties with respect to the subject matter hereof, supersede all existing agreements between them concerning such subject matter, including the Original Agreement,
between the Company and Executive, and may be modified only by a written instrument duly executed by each party. 
 (b) Assignment;
Assumption by Successor. The rights of the Company under this Agreement may, without the consent of Executive, be assigned by the Company, in its sole and unfettered discretion, to any person, firm, corporation or other business entity which at
any 

 
time, whether by purchase, merger or otherwise, directly or indirectly, acquires all or substantially all of the assets or business of the Company. The
Company will require any successor (whether direct or indirect, by purchase, merger or otherwise) to all or substantially all of the business or assets of the Company expressly to assume and to agree to perform this Agreement in the same manner and
to the same extent that the Company would be required to perform it if no such succession had taken place; provided, however, that no such assumption shall relieve the Company of its obligations hereunder. As used in this Agreement, the
“Company” shall mean the Company as hereinbefore defined and any successor to its business and/or assets as aforesaid which assumes and agrees to perform this Agreement by operation of law or otherwise. 
 (c) Survival. The covenants, agreements, representations and warranties contained in or made in Sections 4, 5, 7 and 9 of this Agreement shall
survive any termination of Executive’s employment. 
 (d) Third-Party Beneficiaries. This Agreement does not create, and shall
not be construed as creating, any rights enforceable by any person not a party to this Agreement. 
 (e) Waiver. The failure of either
party hereto at any time to enforce performance by the other party of any provision of this Agreement shall in no way affect such party’s rights thereafter to enforce the same, nor shall the waiver by either party of any breach of any provision
hereof be deemed to be a waiver by such party of any other breach of the same or any other provision hereof. 
 (f) Section Headings.
The headings of the several sections in this Agreement are inserted solely for the convenience of the parties and are not a part of and are not intended to govern, limit or aid in the construction of any term or provision hereof. 
 (g) Notices. All notices, requests and other communications hereunder shall be in writing and shall be delivered by courier or other means of
personal service (including by means of a nationally recognized courier service or professional messenger service), or sent by telex or telecopy or mailed first class, postage prepaid, by certified mail, return receipt requested, in all cases,
addressed to: 
 If to the Company or the Board: 
 Cadence Pharmaceuticals, Inc. 
 ATTN: Secretary 
 12481 High Bluff Drive, Suite 200 
 San Diego, CA 92130 
 If to Executive: 
 At the address listed on the records of the Company 
 All
notices, requests and other communications shall be deemed given on the date of actual receipt or delivery as evidenced by written receipt, acknowledgement or other evidence of actual 

 
receipt or delivery to the address. In case of service by telecopy, a copy of such notice shall be personally delivered or sent by registered or certified
mail, in the manner set forth above, within three business days thereafter. Any party hereto may from time to time by notice in writing served as set forth above designate a different address or a different or additional person to which all such
notices or communications thereafter are to be given. 
 (h) Severability. All Sections, clauses and covenants contained in this
Agreement are severable, and in the event any of them shall be held to be invalid by any court, this Agreement shall be interpreted as if such invalid Sections, clauses or covenants were not contained herein. 
 (i) Governing Law and Venue. This Agreement is to be governed by and construed in accordance with the laws of the State of California applicable
to contracts made and to be performed wholly within such State, and without regard to the conflicts of laws principles thereof. Except as provided in Sections 5 and 7, any suit brought hereon shall be brought in the state or federal courts sitting
in San Diego, California, the parties hereto hereby waiving any claim or defense that such forum is not convenient or proper. Each party hereby agrees that any such court shall have in personam jurisdiction over it and consents to service of process
in any manner authorized by California law. 
 (j) Non-transferability of Interest. None of the rights of Executive to receive any
form of compensation payable pursuant to this Agreement shall be assignable or transferable except through a testamentary disposition or by the laws of descent and distribution upon the death of Executive. Any attempted assignment, transfer,
conveyance, or other disposition (other than as aforesaid) of any interest in the rights of Executive to receive any form of compensation to be made by the Company pursuant to this Agreement shall be void. 
 (k) Gender. Where the context so requires, the use of the masculine gender shall include the feminine and/or neuter genders and the singular shall
include the plural, and vice versa, and the word “person” shall include any corporation, firm, partnership or other form of association. 
 (l) Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same Agreement. 
 (m) Construction. The language in all parts of this Agreement shall in all cases be construed simply, according to its fair meaning, and not
strictly for or against any of the parties hereto. Without limitation, there shall be no presumption against any party on the ground that such party was responsible for drafting this Agreement or any part thereof. 
 (n) Withholding and other Deductions. All compensation payable to Executive hereunder shall be subject to such deductions as the Company is from
time to time required to make pursuant to law, governmental regulation or order. 

 (o) Code Section 409A Exempt. 
 (i) This Agreement is not intended to provide for any deferral of compensation subject to
Section 409A of the Code, and, accordingly, the severance payment payable under Section 4 shall be paid no later than the later of: (A) the fifteenth (15th) day of the third month following Executive’s first taxable year in which such severance benefit is no longer subject to a substantial risk of forfeiture, and (B) the fifteenth (15th) day of the third month following the first taxable year of the Company in which such severance benefit is no longer subject to a substantial risk of
forfeiture, as determined in accordance with Section 409A of the Code and any Treasury Regulations and other guidance issued thereunder. To the extent applicable, this Agreement shall be interpreted in accordance with Section 409A of the
Code and Department of Treasury regulations and other interpretive guidance issued thereunder. 
 (ii) If the Company and Executive
determine that any compensation or benefits payable under this Agreement may be or become subject to Code Section 409A and related Department of Treasury guidance, the Company and Executive agree to amend this Agreement or adopt other policies
or procedures (including amendments, policies and procedures with retroactive effect), or take such other actions as the Company and Executive deem necessary or appropriate to (1) exempt the compensation and benefits payable under this
Agreement from Code Section 409A and/or preserve the intended tax treatment of the compensation and benefits provided with respect to this Agreement, or (2) comply with the requirements of Code Section 409A and related Department of
Treasury guidance. 
 (iii) As provided in Internal Revenue Notice 2007-86, notwithstanding any other provision of this Agreement, with
respect to an election or amendment to change a time and form of payment under this Agreement made on or after January 1, 2008 and on or before December 31, 2008, the election or amendment may apply only to amounts that would not otherwise
be payable in 2008 and may not cause an amount to be paid in 2008 that would not otherwise be payable in 2008. 
 (Signature Page Follows)

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first set forth above.

  

			
	 CADENCE PHARMACEUTICALS, INC.

		
	 By:
	 	  

	 Name:
	 	  

	 Title:
	 	  

	
	  

	 [Name of Executive]

 RELEASE 
 Certain capitalized terms used in this Release are defined in the Second Amended and Restated Employment Agreement by and between CADENCE PHARMACEUTICALS, INC., a Delaware
corporation (the “Company”), and                      (“Executive”) dated as of December 12, 2008 (the
“Agreement”) which Executive has previously executed and of which this Release is a part. 
 Pursuant to the Agreement, and in
consideration of and as a condition precedent to the payments and benefits provided under the Agreement, Executive hereby furnishes the Company with this Release. 
 Executive hereby confirms his/her obligations under the Company’s proprietary information and inventions agreement. 
 On Executive’s own behalf and on behalf of Executive’s heirs, estate and beneficiaries, Executive hereby waives, releases, acquits and forever discharges the Company, and each of its subsidiaries and
affiliates, and each of their respective past or present officers, directors, agents, servants, employees, shareholders, predecessors, successors and assigns, and all persons acting by, through, under, or in concert with them, or any of them, of and
from any and all suits, debts, liens, contracts, agreements, promises, claims, liabilities, demands, causes of action, costs, expenses, attorneys’ fees, damages, indemnities and obligations of every kind and nature, in law, equity, or
otherwise, known and unknown, fixed or contingent, suspected and unsuspected, disclosed and undisclosed (“Claims”), from the beginning of time to the date hereof, including without limitation, Claims that arose as a consequence of
Executive’s employment with the Company, or arising out of the termination of such employment relationship, or arising out of any act committed or omitted during or after the existence of such employment relationship, all up through and
including the date on which this Release is executed, including, but not limited to, Claims which were, could have been, or could be the subject of an administrative or judicial proceeding filed by Executive or on Executive’s behalf under
federal, state or local law, whether by statute, regulation, in contract or tort. This Release includes, but is not limited to: (1) Claims for intentional and negligent infliction of emotional distress; (2) tort Claims for personal injury;
(3) Claims or demands related to salary, bonuses, commissions, stock, stock options, or any other ownership interest in the Company, vacation pay, fringe benefits, expense reimbursements, severance pay, front pay, back pay or any other form of
compensation; (4) Claims for breach of contract; (5) Claims for any form of retaliation, harassment, or discrimination; (6) Claims pursuant to any federal, state or local law or cause of action including, but not limited to, the
federal Civil Rights Act of 1964, as amended, the federal Age Discrimination in Employment Act of 1967, as amended (“ADEA”), the federal Employee Retirement Income Security Act of 1974, as amended, the federal Americans with Disabilities
Act of 1990, the California Fair Employment and Housing Act, as amended, and the California Labor Code; and (7) all other Claims based on tort law, contract law, statutory law, common law, wrongful discharge, constructive discharge, fraud,
defamation, emotional distress, pain and suffering, breach of the implied covenant of good faith and fair dealing, compensatory or punitive damages, interest, attorneys’ fees, and reinstatement or re-employment. If any court rules that
Executive’s waiver of the right to file any administrative or judicial charges or complaints is ineffective, Executive agrees not to seek or accept any money damages or any other relief upon the filing of any such administrative or judicial
charges or complaints. 

 Executive acknowledge that he/she has read and understand Section 1542 of the California Civil Code
which reads as follows: “A general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by him or her must have materially affected
his or her settlement with the debtor.” Executive hereby expressly waives and relinquishes all rights and benefits under that section and any law of any jurisdiction of similar effect with respect to his/her release of any unknown Claims
Executive may have against the Company. 
 Notwithstanding the foregoing, nothing in this Release shall constitute a release by Executive of
any claims or damages based on any right Executive may have to enforce the Company’s executory obligations under the Agreement, any right Executive may have to vested or earned compensation and benefits, or Executive’s eligibility for
indemnification under applicable law, Company governance documents, Executive’s indemnification agreement with the Company, if any, or under any applicable insurance policy with respect to Executive’s liability as an employee or officer of
the Company. 
 If Executive is 40 years of age or older at the time of the termination, Executive acknowledges that he/she is knowingly and
voluntarily waiving and releasing any rights he/she may have under ADEA. Executive also acknowledges that the consideration given under the Agreement for the Release is in addition to anything of value to which he/she was already entitled. Executive
further acknowledges that he/she has been advised by this writing, as required by the ADEA, that: (A) his/her waiver and release do not apply to any rights or claims that may arise on or after the date he/she executes this Release;
(B) Executive has the right to consult with an attorney prior to executing this Release; (C) Executive has 21 days to consider this Release (although he/she may choose to voluntarily execute this Release earlier); (D) Executive has 7
days following the execution of this Release to revoke the Release; and (E) this Release shall not be effective until the date upon which the revocation period has expired, which shall be the 8th day after this Release is executed by Executive,
without Executive’s having given notice of revocation. 
 Executive further acknowledges that Executive has carefully read this Release,
and knows and understands its contents and its binding legal effect. Executive acknowledges that by signing this Release, Executive does so of Executive’s own free will, and that it is Executive’s intention that Executive be legally bound
by its terms. 
  

			
	Print Name:	 	  

	
	  

			
		
	Date:2009 Corporate Bonus Plan

 Exhibit 10.32 
 CADENCE PHARMACEUTICALS, INC. 
 BONUS PLAN 
 Effective January 1, 2009 
 INTRODUCTION
AND PURPOSE 
 The Cadence Pharmaceuticals, Inc. (“Cadence” or the “Company”) Bonus Plan (the “Plan”) is designed to
reward eligible employees for the achievement of corporate objectives, as well as measured individual objectives that are consistent with and support the overall corporate objectives. Since cooperation between departments and employees will be
required to achieve corporate objectives that represent a significant portion of the Plan, the Plan should help foster teamwork and build a cohesive management team. 
 The Plan is designed to: 
  

	•	 	 Encourage high performance by providing an incentive program to achieve overall corporate objectives and to enhance shareholder value. 

 

	•	 	 Reward those individuals who significantly impact corporate results. 

  

	•	 	 Encourage increased teamwork among all disciplines within Cadence. 

  

	•	 	 Incorporate an incentive program in the Cadence overall compensation program to help attract and retain employees. 

  

	•	 	 Provide an incentive for eligible employees to remain employed by Cadence through and beyond the payout of any earned bonus. 

 ELIGIBILITY 
 All regular, exempt, full-time employees at the
Senior Manager level or higher are eligible to participate in the Plan. Employees are not eligible if included in a separate formal incentive plan provided by the Company. In order to be eligible, a participant must have been in an eligible position
for at least three (3) full consecutive months prior to the end of the Plan year, and the participant must remain employed through the end of the Plan year and until awards are paid. If the participant is not employed on the date awards are
paid, the participant will not have earned any bonus. If the participant has been subject to a performance improvement plan or other disciplinary procedure during the Plan year, any award to such individual will be at the discretion of the President
and CEO or the Compensation Committee. 
 Change in Status During the Plan Period: 
  

	 	a.	Participants hired during the Plan year: 

  

	 	•	 	 Participants hired during the Plan year are eligible for a prorated award based the number of months employed in an eligible position. 

	 	•	 	 Participants hired after the end of the third quarter are not eligible to participate for the plan year. 

  

	 	b.	Promotion/change in level:  

  

	 	•	 	 For promotions that occur after April 30th of the
applicable Plan year but prior to October 1st of the applicable Plan year, the calculation will be prorated, based on the number of months at
each bonus percentage level. 

  

	 	•	 	 If the promotion occurred on or after October 1st of the
applicable Plan year, the entire calculation will be based on the bonus percentage applicable prior to the promotion. 

  

	 	c.	Transfer to a position that is included in a separate formal Incentive Plan: 

 Awards will be pro-rated using the same discipline as outlined for promotions above. 
  

	 	d.	Termination of employment:  

  

	 	•	 	 If a participant’s employment is terminated voluntarily prior to the date awards are paid, the participant will not be eligible to receive an award.

  

	 	•	 	 If a participant’s employment is terminated involuntarily prior to the date awards are paid, it will be at the absolute discretion of the Company whether or
not an award payment is made. 

  

	 	e.	Leave of Absence: Employee may be considered for a prorated award. 

 AWARD CALCULATION 
 Awards will be determined by applying a “bonus percentage” to the participant’s base salary in
effect at the end of the Plan year. While the Compensation Committee may change the bonus percentage for any Plan year, the following bonus percentages will initially be used for this purpose: 
  

				
	 Position Title
	  	Bonus Percentage	 
	 President/CEO
	  	60	%
	 EVP, SVP
	  	35	%
	 VP
	  	30	%
	 Senior Director
	  	25	%
	 Director
	  	20	%
	 Associate Director, Senior Manager
	  	15	%

 Corporate and Individual Performance Factors 
 The President and / or CEO will present to the Compensation Committee a list of the overall corporate objectives for the applicable Plan year, which are subject to approval by the Compensation Committee. All
participants in the Plan will then develop a list of key individual objectives, which must be approved by the responsible Vice President or Senior Vice President and by the President and / or CEO. 
 The relative weight between corporate and individual performance factors varies based on the individual’s assigned level within the organization. The weighting may
be reviewed periodically and may be adjusted for any Plan year. The weighting for the performance factors will initially be as follows: 
  

							
	 	  	Corporate	 	 	Individual	 
	 President/CEO
	  	100	%	 		
	 EVP/SVP/VP
	  	60	%	 	40	%
	 All Other
	  	50	%	 	50	%

 Performance Award Multiplier 
 Separate award multipliers will be established for both the corporate and the individual components of each award. The award multiplier for the corporate component shall be determined by the Compensation Committee each Plan year, in its
sole discretion. The same award multiplier for the corporate component of the award shall be used for all Plan participants. The award multiplier for the individual component shall be determined by the responsible Vice President or Senior Vice
President and by the President and / or CEO. 
 While the Compensation Committee may change the award multipliers for any Plan year, the following scale will
be used to determine the actual performance award multiplier based upon the measurement of corporate and individual performance objectives. 
  

					
	 	  	 Performance Category
	  	Award
Multiplier
	 1.
	  	Performance for the year met or exceeded objectives or was excellent in view of prevailing conditions	  	75% - 150%
			
	 2.
	  	Performance generally met the year’s objectives or was very acceptable in view of prevailing conditions	  	50% - 100%
			
	 3.
	  	Performance for the year met some, but not all, objectives	  	25% - 50%
			
	 4.
	  	Performance for the year was not acceptable in view of prevailing conditions	  	0%

 Example 
 The
example below shows a sample cash bonus award calculation under the Plan, which is determined after the end of the performance period. 
 Step #1:
A potential base bonus award is calculated by multiplying the employee’s base salary by their assigned level bonus percentage. 
 Step #2:
The calculated potential base bonus amount is then split between the corporate and individual performance factors by the employee’s assigned level (per the weighting above). This calculation establishes specific potential dollar awards
for the performance period based on both the individual and corporate performance factor components. 
 Step #3: After the end of the
performance period, corporate and individual award multipliers will be established using the criteria described above. Awards are determined by multiplying the potential bonus awards in Step #2 by the actual corporate and individual award
multipliers. 

 Example:           Step # 1: Potential
Base Bonus Award Calculation 
  

					
	 Position:
	  	 	Sr. Director	 
	 Base salary:
	  	$	100,000	 
	 Bonus percentage:
	  	 	20	%
	 Potential base bonus:
	  	$	20,000	 

  

				
	Step # 2: Split award amount based on weighting of Performance Factors
		
	 Potential corporate performance bonus (50%):
	  	$	10,000
	 Potential individual performance bonus (50%):
	  	$	10,000

  

								
	Step # 3: Actual Cash Incentive Award Calculation
	
	Assumed payment multipliers based on assessment of corporate and individual performance:
		
	Corporate multiplier	  	75%-performance generally met objectives
	Individual multiplier	  	125%-performance generally exceeded objectives
	 Cash Award:

	 Corporate component
	  		  	$	 7,500	  	($10,000 × 75%)
	 Individual component
	  		  	$	12,500	  	($10,000 × 125%)
		  		  	 	 	  	
	 Total Award
	  		  	$	20,000	  	

 AWARD PAYMENTS 
 Bonus award payments may be made in cash, through the issuance of stock, stock options or another form of equity award, or by a combination of cash, stock, stock options and/or another form of equity award, at the discretion of the
Compensation Committee. All bonus award payments are subject to applicable tax withholdings. In the event that the Compensation Committee and / or the Board of Directors elect to pay bonus awards in stock or stock options, the Compensation
Committee, in its sole discretion, will make a determination as to the number of shares of stock or stock options to be issued to each Plan participant based, in part, upon the overall corporate performance and each participant’s individual
performance, as described. The issuance of stock and stock options may also be subject to the approval of the Company’s stockholders, and any stock options issued will be subject to the terms and conditions of the Company’s Equity
Incentive Award Plan, as amended from time to time by the Company. 
 Payment of bonus awards will be made as soon as practicable after the issuance of the
Company’s year-end audited Financial Statements for the Plan year, but not later than December 31 of the year following the Plan year. Payments will not be impacted by any benefits, with the exception of elected 401(k) contributions which
will be applied. 

 PLAN PROVISIONS 
 Governance 
 The Plan will be governed by the Compensation Committee of the Board of Directors (the “Compensation Committee”). The
President and / or CEO of Cadence will be responsible for the administration of the Plan. The Compensation Committee will be responsible for approving any compensation or incentive awards to officers of the Company. All determinations of the
Compensation Committee, under the Plan, shall be final and binding on all Plan participants. 
 Compensation Committee’s Absolute Right to Alter or
Abolish the Plan 
 The Compensation Committee reserves the right in its absolute discretion to abolish the Plan at any time or to alter the terms and
conditions under which incentive compensation will be paid. Such discretion may be exercised any time before, during, and after the Plan year is completed. No participant shall have any vested right to receive any compensation hereunder until actual
delivery of such compensation. Participation in the Plan at any given time does not guarantee ongoing participation. 
 Employment Duration/Employment
Relationship 
 This Plan does not, and Cadence’s policies and practices in administering this Plan do not, constitute an express or implied contract
or other agreement concerning the duration of any participant’s employment with the Company. The employment relationship of each participant is “at will” and may be terminated at any time by Cadence or by the participant, with or
without cause. 
 Any questions pertaining to this plan should be directed to the Human Resources Department. 

 Cadence Pharmaceuticals, Inc. 
 Bonus Plan 
 Effective January 1, 2009 
 This is to acknowledge that I have received a copy of the 2009 Bonus Plan. 
  

									
	Name:	  	  
	  		  	Date:	  	  

		  	(Print)	  		  		  	
					
		  	  
	  		  		  	
		  	(Signature)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}]]